Method for the preparation of alpha-bromolactam derivatives

Abstract: The invention is concerned with a new process for the preparation 1. Method for the manufacture of compounds of formula wherein R is hydrogen, lower alkyl, lower alkoxy, cycloalkyl, cycloalkenyl, cycloalkyl-lower alkyl, lower alkenyl, lower alkynyl, aryl, aryl-lower alkyl, heterocyclyl or heterocyclyl-lower alkyl; the lower alkyl, cycloalkyl, lower alkenyl, cycloalkenyl, lower alkynyl, aryl-lower alkyl, aryl and the heterocyclyl moieties being unsubstituted or substituted with at least one group selected from carboxy, amino, carbamoyl, nitro, cyano, lower alkyl, lower alkoxy, hydroxy, halogen, and it is further concerned with the use of compounds prepared according to above mentioned process for the preparation of cephem, isocephem and carbacephem derivatives.

Description: The present invention is related to a method for the manufacture of compounds of formula wherein R is hydrogen, C 1 -C 8 alkyl, halogen-C 1 -C 8 alkyl, C 1 -C 8 alkoxy, C 3 -C 7 cycloalkyl, C 4 -C 7 cycloalkenyl, C 3 -C 7 cycloalkyl-C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, aryl-C 1 -C 8 alkyl, heterocyclyl or heterocyclyl-C 1 -C 8 alkyl; the aryl-C 1 -C 8 alkyl and aryl moieties being unsubstituted or substituted at the aryl moiety with at least one group selected from halogen, hydroxy, cyano, carboxy, carbamoyl, nitro, amino, aminomethyl, C 1 -C 8 alkyl, C 1 -C 8 alkoxy and trifluoromethyl; and heterocyclyl and heterocyclyl-C 1 -C 8 alkyl moieties being unsubstituted or substituted at the heterocyclyl moiety with at least one group selected from C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen, trifluoromethyl, trichloroethyl, amino, mercapto, hydroxy, carboxy and carbamoyl. Compounds of formula I are known compounds. They are used for the manufacture of cephem derivatives as described in EP-A 620 225, carbacephem derivatives as described in EP appl. no. 97116236.7 (EP-A 831093) or isoxacephem derivatives as described in WO 97/26260. In a known process (J. Med. Chem., 1987, 30,1995 - 1998) these lactam derivatives are prepared starting with butyrolactone which is opened and brominated in the presence of elemental bromine and phosphortribromide to form dibromobutyric acid which is reacted with thionylchloride. The resulting 2,4-dibromo-butyric acid chloride is amidated and then transformed to the lactam derivative of formula I. This method is characterised by poor yields of the desired product and undesirable reagents as elemental bromine and phosphortribromide. According to another process (J. Org. Chem., 1995, 60, 1120 - 1130) 2-bromo-4-chloro-butyric acid chloride is obtained by bmmination of 4-chloro-butyric acid chloride with Br 2 and HBr. A further process (Heterocycles, 1988, 27, 1881 - 1885) discloses the preparation of 2,4-dibromo-butyric acid chloride from the corresponding carboxylic acid. As used herein, the terms "C 1 -C 8 alkyl" and "halogen-C 1-8 alkyl" refer to both straight and branched chain saturated hydrocarbon groups having 1 to 8, preferably 1 to 4 carbon atoms, for example, methyl, ethyl, n-propyl, isopropyl, tertiary butyl and the like. The C 1 -C 8 alkyl groups can be unsubstituted or substituted by at least one halogen substituent. Preferred substituents are fluoro, examples of substituted C 1 -C 8 alkyl are trifluoromethyl, trifluoroethyl, perfluorohexyl and the like. By the term "C 1 -C 8 alkoxy" is meant an ether group wherein alkyl is unsubstituted but otherwise as defined above. Examples are methoxy, ethoxy, propyloxy and the like. By the term "C 3 -C 7 cycloalkyl" is meant a 3-7 membered saturated carbocyclic ring e.g., cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and the like. "C 3 -C 7 cycloalkyl-C 1 -C 8 alkyl" is an unsubstituted alkyl group as defined above with an attached C 3 -C 7 cycloalkyl ring. Preferred C 3 -C 7 cycloalkyl-C 1 -C 8 alkyls are for example cyclopropylmethyl or cyclopropylethyl. By the term "C 4 -C 7 -cycloalkenyl" is meant a 4-7 membered carbocyclic ring having at least one olefinic double bond, e.g. cyclopentenyl. As used herein, "C 2 -C 8 alkenyl" refers to an unsubstituted hydrocarbon chain radical having from 2 to 8 carbon atoms, preferably from 2 to 4 carbon atoms, and having at least one olefinic double bond, e.g. vinyl, allyl, and the like. As used herein, "C 2 -C 8 alkynyl" refers to an unsubstituted hydrocarbon chain radical having from 2 to 8 carbon atoms, preferably 2 to 4 carbon atoms, and having at least one triple bond. The term "halogen" used herein refers to chlorine or chloro; bromine or bromo; iodine or iodo; and fluorine or fluoro. By the term "aryl" is meant a radical derived from an aromatic hydrocarbon by the elimination of one atom of hydrogen and can be substituted or unsubstituted. The aromatic hydrocarbon can be mononuclear or polynuclear. Examples of aryl radicals of the mononuclear type include phenyl, tolyl, xylyl, mesityl, cumenyl, and the like. Examples of aryl radicals of the polynuclear type include naphthyl, anthryl, phenanthryl, and the like. The aryl group can have at least one substituent selected from halogen, hydroxy, cyano, carboxy, carbamoyl, nitro, amino, aminomethyl, C 1 -C 8 alkyl, C 1 -C 8 alkoxy or trifluoromethyl. Examples include 2-fluorophenyl, 3-nitrophenyl, 4-nitrophenyl, 4-methoxyphenyl, 4-hydroxyphenyl, and the like. By the term "aryl-C 1 -C 8 alkyl" is meant an unsubstituted C 1 -C 8 alkyl group containing an aryl group as defined above, for example benzyl. As used herein, "heterocyclyl" refers to an unsaturated or saturated, unsubstituted or substituted 5-, 6-, or 7-membered heterocyclic ring containing at least one hetero atom selected from the group consisting of oxygen, nitrogen, or sulfur. Exemplary heterocyclic rings include, but are not limited to, e.g., the following groups: pyrrolidinyl, pyridyl, pyridiniumyl, pyrazinyl, piperidyl, piperidino, N-oxido-pyridyl, pyrimidyl, piperazinyl, pyrrolidinyl, pyridazinyl, N-oxide-pyridazinyl, pyrazolyl, triazinyl, imidazolyl, thiazolyl, 1,2,3-thiadiazolyl, 1,2,4-thiadiazolyl, 1,3,4-thiadiazolyl, 1,2,5-thiadiazolyl, 1,2,3-oxadiazolyl, 1,2,4-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,2,3-triazolyl, 1,2,4-triazolyl, 1H-tetrazolyl, 2H-tetrazolyl, thienyl, azetidinyl, furyl, hexamethyleneiminyl, oxepanyl, 1H-azepinyl, thiophenyl, tetrahydrothiophenyl, 3H-1,2,3-oxathiazolyl, 1,2,3-oxadiazolyl, 1,2,5-oxadithiolyl, isoxazolyl, isothiazolyl, 4H-1,2,4-oxadiazinyl, 1,2,5-oxathiazinyl, 1,2,3,5-oxathiadiazinyl, 1,3,4-thiadiazepinyl, 1,2,5,6-oxatriazepinyl, oxazolidinyl, tetrahydrothienyl, and the like. Preferred heterocyclic rings are pyridyl, pyridiniumyl, piperidyl, pyrrolidinyl and azetinyl. Substituents for the heterocyclic ring include C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen, trifluoromethyl, trichloroethyl, amino, mercapto, hydroxy, carboxy and carbamoyl. Preferred examples of substituted heterocyclic rings include 5-methyl-isoxazol-3-yl, N-methyl-pyridinium-2-yl, N-methyl-pyrrolidinyl, 1-methyl-tetrazolyl and N-aryl-carbamoyl, methyl-pyridinium-2-yl. The heterocyclic ring can also be substituted by an optionally substituted phenyl ring such as 2,6-dichlorophenyl. Preferred is 2,6-dichlorophenyl-5-methyl-isoxazolyl. A further substituent of the heterocyclic ring is oxo, such as in 2-oxo-oxazolidin-3-yl, 1,1-dioxotetrahydrothien-3-yl. The heterocyclic ring can also be fused together with a benzene ring. As used herein, "heterocyclyl-C 1 -C 8 alkyl" refers to an unsubstituted C 1 -C 8 alkyl group containing a heterocyclic group as defined above, e.g. tetrazolyl-methyl, tetrahydrofuranyl-methyl, thiophenyl-methyl or benzimidazolyl-methyl. It has been found that compounds of formula I can be manufactured in an improved and more economic manner by the two step method according to the invention, which consist of a) reacting 4-chloro-butyric acid chloride ( 1 ) with N-bromosuccinimide in an inert solvent by adding first thionylchloride, immediately followed by a catalytic amount of hydrobromic acid to form a compound of formula b) and reacting the compound (2) with an amine of formula R-NH 2 wherein R is as defined above in a non-aqueous medium in presence of sodium or potassium hydroxide and a phase transfer catalyst according to the reaction scheme 1 depicted below to yield the desired lactam of formula I in high yields. wherein R is as defined above. The bromination of 4-chloro-butyric acid chloride ( 1 ) proceeds smoothly and the formation of by-products when the reaction is carried out in an inert solvent, preferably a chlorinated hydrocarbon as for example dichloromethane, tetrachloromethane and the like, by suspending the acid chloride ( 1 ) and the N-bromo-succinimide in a ratio 1 to 1.5 molar and subsequently adding 5 to 10 mol % thionylchloride, preferably 5 mol %, immediately followed by a catalytic amount, preferably 3 mol% with respect to the acid chloride, of hydrobromic acid. The brominated acid chloride ( 2 ) is then - without any further purification - reacted with a R-substituted amine ( 3 ) to form the amide ( 4 ) which is cyclised in situ to yield the substituted lactam of formula L According to the invention the formation of the amide ( 4 ) and the cyclisation reaction are carried out in a single step by suspending sodium or potassium hydroxide, preferably as anhydrous pearls, together with a phase transfer catalyst in a non-aqueous medium and adding under vigorous stirring the R-substituted amine ( 3 ) followed by a solution containing the brominated acid chloride ( 2 ). During the addition of ( 2 ) the reaction temperature raises and is then maintained at about 40°C to 45°C during the reaction. The method according to the invention improves the preparation of compounds of formula I by shortening the process, by obtaining higher yields, and by avoiding problematic reagents, as elemental bromine and by decreasing the production costs. Compounds of formula I prepared according to the invention can be used for the manufacture of cephem, carbacephem and isoxacephem derivatives of formula wherein R 1 is hydrogen, optionally substituted C 1 -C 8 alkyl, C 3 -C 7 cycloalkyl, aryl - C 1 -C 8 alkyl, trityl, acetyl or tetrahydropyranyl; R is as defined above; Y is -S- and Z is -CH 2 - or Y is -CH 2 - and Z is -O-, or Y and Z are -CH 2 -; and X is -CH- or nitrogen. The following examples illustrate the invention in more detail and are not intended to be a limitation in any manner. Example 1 Procedure for the Preparation of 2-Bromo-4-chloro-butyric acid chloride In a 1.5-litre 4-necked flask, equipped with a stirrer, reflux condenser, thermometer and argon inlet, 280.0 g 4-chloro-butyric acid chloride (1.98 mol) and 546.0 g N-bromosuccinimide (3.06 mol) were suspended with stirring, under argon in 560 ml dichloromethane; 12.0 g thionylchloride (0.10 mol) were added to the mixture, immediately followed by 3.60 ml 48% hydrobromic acid. The initially yellowish solution turned dark orange. The reaction mixture was refluxed during 1.5 h. The red-brown solution was evaporated. The resulting orange residue (800.7 g) was dispersed in 1.401 n-hexane during 5 minutes, filtered under argon and the residue washed with n-hexane. The combined filtrates were evaporated to yield 352 g of 2-bromo-4-chloro-butyric acid chloride as yellowish oil. This product could be used in further steps without purification. Example 2 2.1. Procedure for the Preparation of N-Cyclopropylmethyl-3-bromopyrrolidine-2-one In a 1.5-litre 4-necked flask, equipped with a stirrer, dropping funnel, reflux condenser, thermometer and argon inlet, 54.4 g sodium hydroxide pearls (1.36 mol) and 9.26 g tetrabutylammonium hydrogensulfate (27.3 mmol) were suspended with stirring at room temperature under argon in 500 ml dichloromethane. To the suspension 35.6 g aminomethylcyclopropane (500 mmol) were added. A solution of 100.0 g 2-bromo-4-chlorobutyric acid chloride (400 mmol, product of Example 1) in 100 ml dichloromethane was added during 10 min. After the first 3 min of addition, reflux was reached and maintained during the addition. After completed addition, the mixture was refluxed for 1 h, during which its colour changed from dark green to dark brown. The suspension was cooled to room temperature during 10 min, and a mixture of 50 g ice and 250 ml deionized water was added under stirring. The phases were separated and the organic layer was successively washed with a solution of 60 g ammonium chloride in 300 ml deionized water, followed by 300 ml deionized water. The organic layer was concentrated to yield 94.2 g of N-cyclopropylmethyl-3-bromopyrrolidine-2-one as a dark oil. 2.2. Procedure for the preparation of N-isobutyl-3-bromopyrrolidine-2-one In a 1.5-litre 4-necked flask, equipped with a stirrer, reflux condenser, thermometer and argon inlet, 54.4 g NaOH pearls (1.36 mol) and 9.26 g tetrabutylammonium-hydrogensulfate (27.3 mmol) were suspended at room temperature under argon in 500 ml dichloromethane. To this suspension 36.6 g isobutylamine (500 mol) were added. Under stirring 100.0 g 2-bromo-4-chlorobutyric acid chloride (400 mol, product of Example 1) in 100 ml dichloromethane were added in 10 min. After the first three minutes of addition reflux of the mixture was reached and maintained during the addition. Reflux of the mixture was continued for 2.0 h. After the first 10 minutes, the initially yellowish suspension turned purple, then gradually faded into grey. After completed reflux, the mixture was allowed to cool to room temperature during 15 min, a mixture of 50 g ice in 250 ml deionized water was added under stirring during 1 min, and the phases were separated. The organic phase was first washed with a solution of 60 g ammonium chloride in 300 ml deionized water, then with 300 ml deionized water, and finally evaporated to yield 84.3 g of N-isobutyl-3-bromopyrrolidine-2-one as a dark oil. 2.3. N-Cyclopropyl-3-bromopyrrolidin-2-one was prepared in analogy to the procedure described in Examples 2.1. and 2.2. using cyclopropylamine instead of methylcyclopropane and isobutylamin, respectively.

Claims: Method for the manufacture of compounds of formula wherein R is hydrogen, C 1 -C 8 alkyl, halogen-C 1 -C 8 alkyl, C 1 -C 8 alkoxy, C 3 -C 7 cycloalkyl, C 4 -C 7 cycloalkenyl, C 3 -C 7 cycloalkyl-C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, aryl, aryl-C 1 -C 8 alkyl, heterocyclyl or heterocyclyl-C 1 -C 8 alkyl; the aryl-C 1 -C 8 alkyl and aryl moieties being unsubstituted or substituted at the aryl moiety with at least one group selected from halogen, hydroxy, cyano, carboxy, carbamoyl, nitro, amino, aminomethyl, C 1 -C 8 alkyl, C 1 -C 8 alkoxy and trifluoromethyl; and heterocyclyl and heterocyclyl-C 1 -C 8 alkyl moieties being unsubstituted or substituted at the heterocyclyl moiety with at least one group selected from C 1 -C 8 alkyl, C 1 -C 8 alkoxy, halogen, trifluoromethyl, trichloroethyl, amino, mercapto, hydroxy, carboxy and carbamoyl. which process is characterised by a) reacting 4-chloro-butyric acid chloride with N-bromosuccinimide in an inert solvent by adding first 5 to 10 mol % thionylchloride, immediately followed by a catalytic amount of hydrobromic acid to form the compound of formula b) and reacting the compound (2) with an amine of formula R-NH 2 wherein R is as defined above, in a non-aqueous medium in the presence of sodium or potassium hydroxide and a phase transfer catalyst. A process according to claim 1 wherein the amount of thionylchloride is 5 mol% and the amount of hydrobromic acid is 3 mol%. A process according to claim 1 wherein the inert solvent is dichloromethane. A process according to claim 1 wherein the sodium- or potassium hydroxide is present in form of anhydrous pearls. A process according to any one of claims 1 to 4 for the preparation of compounds of formula I wherein R is C 1 -C 8 alkyl, C 3 -C 7 cycloalkyl, C 3 -C 7 cycloalkyl-C 1 -C 8 alkyl, halogen-C 1 -C 8 alkyl or heterocyclyl defined as in claim 1. Process according to claim 5 for the preparation of compounds of formula I wherein R is isobutyl, cyclopropyl, cyclopropylmethyl, trifluoroethyl or pyrrolidyl. A process according to any one of claims 1 to 6, further characterized in that cephalosporins of formula wherein R 1 is hydrogen, optionally substituted C 1 -C 8 alkyl, C 3 -C 7 cycloalkyl, aryl-C 1 -C 8 alkyl, trityl, acetyl or tetrahydropyranyl; R and "aryl" are as defined in claim 1; Y is -S- and Z is -CH 2 - or Y is -CH 2 - and Z is -O-, or Y and Z are -CH 2 -; and X is -CH- or nitrogen, are prepared.

Inventors: ABRECHT STEFAN, ABRECHT, STEFAN
Applicants: BASILEA PHARMACEUTICA AG
Application year: 1998
Main classification: C07D207
IPC codes: C07D498, C07D507, C07D207, C07D501, C07D505